Advertisement: TTP
Mid banner advertisement: BDO
Advertisement Cambridge China Centre
RealVNC mid-banner general
Advertisement: Mogrify
Advertisement: Bradfield Centre mid
RealVNC mid banner careers
ARM Innovation Hub
Advertisement: RSM
Advertisement: Wild Knight Vodka
Advertisement EY mid banner
Advertisement: Cambridge Network
Barr Ellison Solicitors – commercial property
5 March, 2014 - 10:47 By News Desk

Antibody development against hard-to-produce antigens

Monoclonal-antibodies

A Belgian SME has developed a novel immunization method that generates efficient antibodies without using recombinant proteins or purified proteins.

Poly- and monoclonal antibodies are delivered even against self-antigens, membrane or insoluble proteins, low immunogenic proteins or peptides. The company seeks industrial and academic partners active in biotechnology R&D for technical collaboration (for development of therapeutic or diagnostic preclinical candidates for example).

Closing date: 14/02/2015

Ref: TRBE20140109001

Add new comment

Newsletter Subscription

Stay informed of the latest news and features